By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Entertainment > Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement
Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement
Entertainment

Emerald Clinical Trials Honored with 2026 Asia Pacific Biopharma Excellence Award for Outstanding Patient Recruitment & Engagement

PRNW Agency
Last updated: 12/03/2026 9:37 PM
PRNW Agency
Published: 12/03/2026
Share
SHARE

SINGAPORE, March 12, 2026 /PRNewswire/ — Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced it has been named a winner of a 2026 Asia Pacific Biopharma Excellence Award (ABEA). The company was recognized with the Best Clinical Trials Supplier Award: Outstanding Patient Recruitment & Engagement. 

- Advertisement -

The ABEA award highlights Emerald’s ability to navigate the complex recruitment landscapes of the Asia-Pacific region, ensuring that life-changing therapies reach patients with both speed and compassion.

- Advertisement -

“This recognition is a testament to our team’s dedication to solving the most complex challenges in clinical development,” said Chantal Elbayeh, Executive Director, Project Delivery at Emerald Clinical Trials. “By bridging the gap between innovative science and patient access, Emerald is not just facilitating trials—we are facilitating hope. This award reinforces our role at the forefront of strengthening the biopharmaceutical ecosystem and advancing the availability of breakthrough therapies for patients worldwide.”

- Advertisement -

The ABEA serves as a benchmark for industry leaders and trend-setters who have made significant contributions to the advancement of biologics and pharmaceutical products. Emerald Clinical Trials was selected for its unparalleled commitment to patient-centric strategies and its operational excellence in the APAC region.

- Advertisement -

The formal award ceremony took place on Wednesday, March 11, 2026, at the Sands Expo & Convention Centre, Singapore, where Emerald was recognized alongside the region’s top biopharma innovators.

- Advertisement -

About Emerald Clinical Trials
Emerald Clinical Trials is a global clinical research organization with 25+ years of experience, partnering with over 160 biotech companies and 15 of the world’s top 20 pharmaceutical firms. Headquartered in Singapore, the company delivers end-to-end Phase I–IV and real-world trial solutions, with recognized leadership in renal research. With 800+ employees worldwide, Emerald Clinical combines global reach with local expertise to accelerate trials and advance healthcare. For more information, visit www.emeraldclinical.com.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2657673/George_Clinical__Emerald_Clinical_Trials__logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/emerald-clinical-trials-honored-with-2026-asia-pacific-biopharma-excellence-award-for-outstanding-patient-recruitment–engagement-302711503.html

- Advertisement -
Yatra Celebrates 19 Years with The Yatra Big Outing Fest
MALAYSIA’S PREMIER TRANSSHIPMENT HUB SELECTS GEP SOFTWARE FOR CONTRACT MANAGEMENT
Inventiva reports preliminary 2025 fiscal year financial results
Release of the Latest Ecological Documentary on Huangyan Dao: An Unfading Commitment: Why Huangyan Dao Needs Protection
FAIR PLAY MENARINI INTERNATIONAL AWARD, THE 2025 EDITION BEGINS WITH THE ANNOUNCEMENT OF THIS YEAR’S AWARDEES AT CONI
TAGGED:2026asiaawardbiopharma,clinicalemeraldengagementexcellenceforhonorednewsoutstandingpacific,patientrecruitmenttrialswith
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
OMAN INVESTMENT AUTHORITY REPORTS USD 4.1 BILLION PROFIT FOR 2024, RANKS AMONG TOP 10 GLOBAL SOVEREIGN FUNDS
News

OMAN INVESTMENT AUTHORITY REPORTS USD 4.1 BILLION PROFIT FOR 2024, RANKS AMONG TOP 10 GLOBAL SOVEREIGN FUNDS

03/07/2025
Ride for a Cause, Rally for a Cure: Manipal Hospital Yeshwanthpur Leads the Charge Against Breast Cancer
ROLLER and Activeon Strengthen Long-Term Partnership to Power the Next Stage of Growth for 72+ Locations
Netcore Empanelled with NICSI to Support Nationwide Citizen Communication Across SMS and RCS
Enovis to Participate in Upcoming Investor Conferences
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?